fda compounding semaglutide news september 2025 Drug compounders sue over declaration ending Wegovy shortage For patients with #obesity, semaglutide,
Description
Access may be subject to limitations based on institutional regulations and data protection policies
Be mindful of how your semaglutide administration affects your body
If new legislation or FDA policy changes emerge from the case, broader reforms could be implemented, affecting how shortages are determined and how compounding exemptions are granted in the future
It's not just about having the right BMI
Previous literature has highlighted the role of ancestry 11 and T2D status 14 in determining GLP1 medication efficacy for weight loss
